Caitlin M. Gordon, Billy Yu, Frank Leung, Michael Legal, Janet Simons, Erica Wang, Michelle Gnyra
{"title":"Characterizing Stigmatizing and Biased Language in Clinical Pharmacist Documentation","authors":"Caitlin M. Gordon, Billy Yu, Frank Leung, Michael Legal, Janet Simons, Erica Wang, Michelle Gnyra","doi":"10.1002/jac5.70119","DOIUrl":"https://doi.org/10.1002/jac5.70119","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Biased language in documentation can perpetuate stigma, influence treatment decisions, and impact provider–patient relationships. As any person seeking care at acute care hospitals may face stigma, particularly those with substance use or mental health disorders, unbiased documentation is crucial. We sought to determine the prevalence of stigmatizing and biased language in electronic health records written by clinical pharmacists.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This study was conducted at two acute care teaching hospitals, St. Paul's and Mount Saint Joseph Hospitals in Vancouver, British Columbia, Canada. A list of stigmatizing and biased terms was compiled through literature review and expert consensus. A retrospective, observational, cross-sectional study of clinical pharmacist notes was performed using a data-mining algorithm to identify these terms. A content analysis was conducted to explore the ways this terminology was used and to uncover new themes not previously documented in the literature.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Between November 16, 2019, and September 30, 2023, of 135 671 clinical pharmacist notes reviewed, 42 192 (31.1%) contained at least one stigmatizing or biased term. Commonly identified terms included: compliance, noncompliance, refuses, denies, and smoker. All themes previously documented in the literature (e.g., leading with race/socioeconomic status, incorrect pronouns, employing quotations to suggest lack of credibility) were observed. Additionally, new themes emerged, including the use of punctuation or formatting to amplify the stigmatizing tone and the role of electronic health records in perpetuating stigma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>Stigmatizing language was found in 31.1% of clinical pharmacist notes. Findings from this study are assisting in the development of a multimodal educational intervention aimed at reducing the prevalence of stigmatizing language in clinical pharmacist documentation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 10","pages":"974-982"},"PeriodicalIF":1.5,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://accpjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.70119","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145248508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comment on “Consensus Recommendations for the Integration of Critical Care Pharmacists on Intensive Care Unit Teams: Endorsed by the American Association of Critical-Care Nurses, American College of Clinical Pharmacy, American Society of Health-System Pharmacists, Institute for Safe Medication Practices, and Society of Critical Care Medicine”","authors":"John Carr, Dustin Orvin","doi":"10.1002/jac5.70117","DOIUrl":"https://doi.org/10.1002/jac5.70117","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 10","pages":"1101-1102"},"PeriodicalIF":1.5,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145248547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mojdeh S. Heavner, Jason J. Heavner, Brian Murray, Andrea Sikora
{"title":"Response to Comment on “Consensus Recommendations for the Integration of Critical Care Pharmacists on Intensive Care Unit Teams: Endorsed by the American Association of Critical-Care Nurses, American College of Clinical Pharmacy, American Society of Health-System Pharmacists, Institute for Safe Medication Practices, and Society of Critical Care Medicine”","authors":"Mojdeh S. Heavner, Jason J. Heavner, Brian Murray, Andrea Sikora","doi":"10.1002/jac5.70116","DOIUrl":"https://doi.org/10.1002/jac5.70116","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 10","pages":"1103-1104"},"PeriodicalIF":1.5,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145248772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"PSAP in JACCP Case Series: Hypertension","authors":"Andrew Y. Hwang, Christina H. Sherrill","doi":"10.1002/jac5.70102","DOIUrl":"10.1002/jac5.70102","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 9","pages":"962-963"},"PeriodicalIF":1.5,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145038357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"PSAP in JACCP Recorded Webcast: Behavioral Approaches to Optimize Patient Engagement in a Healthy Lifestyle","authors":"Lauren M. Hynicka, Richard J. Rovelli","doi":"10.1002/jac5.70101","DOIUrl":"10.1002/jac5.70101","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 9","pages":"964-965"},"PeriodicalIF":1.5,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145038302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sara Lingow, Nicholas Carris, Jennifer Clements, Lindsay Courtney, Abby Lennon, Christina H. Sherrill, Elizabeth Van Dril
{"title":"The Pharmacist's Role in the Use of Incretin-Based Therapies for Weight Management: An Opinion of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy","authors":"Sara Lingow, Nicholas Carris, Jennifer Clements, Lindsay Courtney, Abby Lennon, Christina H. Sherrill, Elizabeth Van Dril","doi":"10.1002/jac5.70111","DOIUrl":"https://doi.org/10.1002/jac5.70111","url":null,"abstract":"<p>The popularity of incretin-based therapies has increased substantially over the past several years due to their clinically significant efficacy for weight loss and positive impact on weight-related comorbid conditions, yet, few clinical practice guidelines for the management of overweight and obesity have been updated to incorporate these agents. The increased demand for incretin-based therapies for weight management has revealed barriers to their implementation related to cost, availability, and emerging safety concerns. This opinion paper aims to briefly review the available literature on the current role of incretin-based therapy for chronic weight management in persons with overweight or obesity and provide recommendations for clinical pharmacists utilizing these agents. The intent of this opinion paper is to discuss the benefits and risks of incretin-based therapy for weight management, review approaches for clinical pharmacists to overcome barriers to their implementation, and address ongoing questions related to their use. Finally, the authors suggest an approach to the management of people with overweight or obesity with incretin-based therapy using the Pharmacists' Patient Care Process along with actions clinical pharmacists can take to ensure best practices with these agents.</p>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 10","pages":"1078-1093"},"PeriodicalIF":1.5,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://accpjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.70111","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145248770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kenneth C. Hohmeier, Grace Broussard, Melissa Tyszko, Kelly Barland, Kristi Carlston, Yingjia Wei, Craig Field, Adam J. Gordon, Alina Cernasev, Gerald Cochran
{"title":"Impact of Community Pharmacists on Reducing Opioid and Alcohol Co-Use: A Pilot Randomized Control Trial of a Medication Therapy Management Intervention","authors":"Kenneth C. Hohmeier, Grace Broussard, Melissa Tyszko, Kelly Barland, Kristi Carlston, Yingjia Wei, Craig Field, Adam J. Gordon, Alina Cernasev, Gerald Cochran","doi":"10.1002/jac5.70113","DOIUrl":"https://doi.org/10.1002/jac5.70113","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Concurrent use of opioids and alcohol can result in respiratory depression, overdose, and death. Prior research has shown that 20%–30% of patients receiving opioid medications in community pharmacies engage in high-risk drinking. We adapted a medication therapy management-based intervention to address co-use and tested its feasibility, acceptability, and preliminary efficacy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>This pilot study enrolled adult, English-speaking community pharmacy patients dispensed opioids who reported current drinking. Participants were randomized to standard medication counseling (SMC) or alcohol-targeted brief intervention-medication therapy management (ABI-MTM). ABI-MTM included two pharmacist-delivered sessions focused on reviewing medications/interactions, motivating participants to discontinue co-use, and providing a written action plan. We assessed enrollment, retention, intervention delivery, satisfaction, drinks per drinking day (DDD), and daily morphine milligram equivalent (MME) at baseline, 2, and 3 months. Outcomes were analyzed using descriptive statistics and generalized linear mixed modeling.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We enrolled 44 patients (110% of target; 22 per group). No significant differences were found in age (mean = 55.8), sex (female = 65.9%), race (White = 95.5%), education (> high school = 95.5%), or health insurance status (insured = 95.5%). Consent and retention rates exceeded 90%, session delivery was ≥ 95%, and ABI-MTM satisfaction ranged from 79% to 89%. At 3 months, 59.1% of ABI-MTM participants versus 45.5% of SMC achieved ≥ 30% reduction in DDD and/or daily MME. Mixed models showed ABI-MTM recipients had 2.10 (95% confidence interval = 0.34–12.95) higher odds of achieving this reduction.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>ABI-MTM demonstrated feasibility, acceptability, and preliminary efficacy. A fully powered trial is warranted to evaluate broader implementation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 10","pages":"991-1002"},"PeriodicalIF":1.5,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145248593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Pharmacy Workforce: Proud but Unhappy","authors":"Stuart T. Haines","doi":"10.1002/jac5.70112","DOIUrl":"https://doi.org/10.1002/jac5.70112","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 10","pages":"970-973"},"PeriodicalIF":1.5,"publicationDate":"2025-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145248401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alexis A. Anthony, Ashlyn M. Kiebach, Lisa E. Dumkow, Jessica A. Benzer
{"title":"Impact of a Pharmacy Intern-Led Electronic Health Record Outreach Program on Vaccine Uptake in a Primary Care Network","authors":"Alexis A. Anthony, Ashlyn M. Kiebach, Lisa E. Dumkow, Jessica A. Benzer","doi":"10.1002/jac5.70110","DOIUrl":"https://doi.org/10.1002/jac5.70110","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Despite the demonstrated benefits of vaccination, rates of recommended vaccine uptake among adults and children in the United States continue to remain low. Pharmacy interns are well-positioned to champion clinical programs. A pharmacy intern-led outreach program utilizing the electronic health record (EHR) messaging system may be a way to increase vaccination uptake.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>The primary objective was to assess the percent of patients vaccinated following the implementation of a pharmacy intern-led vaccine outreach program.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This was a retrospective cohort study evaluating patients from 17 primary care sites who were eligible for pneumococcal, Herpes Zoster, meningococcal, or hepatitis B vaccine and received an outreach message from the pharmacy intern. The intern sent EHR messages with vaccine recommendations from November 2023 until August 2024. The primary outcome evaluating the percentage of patients vaccinated was assessed at 6 months following the final day of outreach. Secondary outcomes of this study were to describe the uptake of each vaccine and to assess differences in the demographics of patients receiving the different vaccination types. Program time commitment and revenue were also assessed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 99 625 outreach messages were sent with 4518 (4.5%) of patients vaccinated. Of the 59 494 (59.7%) patients who read the outreach message, 7.6% of patients received the recommended vaccine compared to 0% of patients who did not read the message (<i>p</i> < 0.001). Of the patients eligible for each vaccination type who read the messaging, a total of 2188 (10.1%) patients received a pneumococcal vaccine, 1496 (10.5%) received a Herpes Zoster vaccine, 281 (47.3%) received a meningococcal vaccine, and 553 (2.4%) patients received a hepatitis B vaccine. The program was associated with an estimated $310 973 in revenue.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>A pharmacy intern-led outreach program conducted via EHR messaging demonstrated a significant increase in vaccination uptake and may be financially self-sustainable.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 10","pages":"983-990"},"PeriodicalIF":1.5,"publicationDate":"2025-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145248748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Michael L. Behal, Laura M. Ebbitt, Katie M. Ruf, Katherine M. Spezzano, Alexandra M. Wiegand, Komal A. Pandya
{"title":"Cross-Sectional Survey of Critical Care Pharmacy Residency Programs: Post-Residency Positions Acquired and Job Market Perceptions","authors":"Michael L. Behal, Laura M. Ebbitt, Katie M. Ruf, Katherine M. Spezzano, Alexandra M. Wiegand, Komal A. Pandya","doi":"10.1002/jac5.70098","DOIUrl":"https://doi.org/10.1002/jac5.70098","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Historically, there has been a perception that the critical care (CC) job market is saturated; however, there is no confirmation about whether the job market can support residency graduates.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To characterize the Post Graduate Year Two (PGY2) CC residency program director (RPD) and resident graduate perceptions of the CC job market.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A survey was sent to United States-based PGY2 CC pharmacy residency graduates from 2018 to 2023. Demographics, PGY2 CC program data, and post-residency job and job market perceptions data were collected. A similar survey was sent to US-based RPDs. Demographics and job market perceptions data were collected. Descriptive statistics were used to summarize the data. PGY2 CC resident graduate and RPD perceptions of the CC job market were compared. The Consensus-Based Checklist for Reporting of Survey Studies (CROSS) was utilized to ensure methodological rigor and comprehensive reporting of this survey-based study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Surveys were completed by 51 RPDs (29.7% response rate) and 138 residents (42.3% response rate). The majority of graduates secured full-time positions, with 111 respondents (80.4%) accepting their first-choice job. Residents identified practice specialty, geographic location, and schedule consistency as critical job selection factors. RPDs and residents reported a predominantly balanced or favorable CC job market, with perceptions aligning across groups. Although some residents faced challenges securing positions in preferred specialty areas or geographic locations, 120 residents (87%) reported their first job matched their residency training well or very well.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>PGY2 CC pharmacy residents who graduated between 2018 and 2023 successfully secured positions within their specialty, with most accepting their preferred roles. These findings suggest a favorable job market and highlight opportunities for RPDs to guide residents in navigating job market realities effectively. Further studies could explore longitudinal job satisfaction and the impact of evolving market conditions.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"8 10","pages":"1003-1014"},"PeriodicalIF":1.5,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145248658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}